Cargando…
Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation
Sitagliptin is an emerging oral hypoglycemic agent that inhibits the development of a wide variety of tumors. Current researches indicate that the abnormal activation of Yes‐associated protein (YAP) promotes the proliferation and poor prognosis of multiple tumors. However, the ability of sitagliptin...
Autores principales: | Wang, Qi, Lu, Pan, Wang, Tao, Zheng, Qianqian, Li, Yan, Leng, Sean X., Meng, Xin, Wang, Biao, Xie, Jisheng, Zhang, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286447/ https://www.ncbi.nlm.nih.gov/pubmed/32227453 http://dx.doi.org/10.1002/cam4.3024 |
Ejemplares similares
-
Overexpression of Yes‐associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta‐analysis
por: Lin, Chengjie, et al.
Publicado: (2017) -
Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signalling
por: Wang, Jiaqi, et al.
Publicado: (2020) -
Yes-Associated Protein Contributes to Cell Proliferation and Migration of Gastric Cancer via Activation of Gli1
por: Han, Ting, et al.
Publicado: (2020) -
The role of DOT1L in the proliferation and prognosis of gastric cancer
por: Song, Zaozhi, et al.
Publicado: (2020) -
XEDAR inhibits the proliferation and induces apoptosis of gastric cancer cells by regulating JNK signaling pathway
por: Yang, Lihong, et al.
Publicado: (2019)